Inflammation in end-stage renal disease: sources, consequences, and therapy (Q34928704)

5 August 2017

1 reference

title

Inflammation in end-stage renal disease: sources, consequences, and therapy (English)

1 reference

5 August 2017

1 reference

1

Peter Stenvinkel

1 reference

5 August 2017

Anders Alvestrand

2

1 reference

PubMed ID

12358637

5 August 2017

language of work or name

1 reference

1 September 2002

1 reference

5 August 2017

1 reference

5 August 2017

15

1 reference

5 August 2017

329-337

1 reference

5 August 2017

5

1 reference

Is renal insufficiency an atherogenic state? Reflections on prevalence, incidence, and risk

5 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Inflammatory and atherosclerotic interactions in the depleted uremic patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Inflammation in end-stage renal failure: could it be treated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Inflammatory effects of peritoneal dialysis: evidence of systemic monocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. The HEMO Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

C reactive protein in patients with chronic renal diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Accelerated coronary atherosclerosis and arteriosclerosis in young human-immunodeficiency-virus-positive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Mortality, malnutrition, and atherosclerosis in ESRD: what is the role of interleukin-6?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: association with Chlamydia pneumoniae seropositivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Fibrin as a factor in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Interleukin-6 exacerbates early atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Involvement of interleukin-6 in atherosclerosis but not in the prevention of fatty streak formation by 17beta-estradiol in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Insulin resistance in uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Immunologic function and survival in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Effects of tumor necrosis factor-alpha on insulin action in cultured human muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Mechanisms involved in tumor necrosis factor-alpha induction of insulin resistance and its reversal by thiazolidinedione(s).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

The contribution of skeletal muscle tumor necrosis factor-alpha to insulin resistance and hypertension in fructose-fed rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Serial circulating concentrations of C-reactive protein, interleukin (IL)-4, and IL-6 in patients with acute left heart decompensation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Effects of simvastatin on high-sensitivity C-reactive protein and serum albumin in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Effects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidemic non-insulin dependent diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Treatment of malnourished CAPD patients with an amino acid based dialysate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Nutritional modulation of cytokine biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Vitamin E and leukocyte-endothelial cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Oxidative stress is reduced by the long-term use of vitamin E-coated dialysis filters

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

MODERATE DOSES OF ASPIRIN AND RISK OF BLEEDING IN RENAL FAILURE

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Elevated C-reactive protein levels in overweight and obese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

Inflammation and outcome in end-stage renal failure: Does female gender constitute a survival advantage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2002.00083.X

10.1046/J.1525-139X.2002.00083.X

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12358637